iSpecimen Inc.
ISPC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $9,291 | $9,928 | $10,402 | $11,135 |
| % Growth | -6.4% | -4.6% | -6.6% | – |
| Cost of Goods Sold | $5,303 | $4,820 | $4,757 | $5,249 |
| Gross Profit | $3,988 | $5,108 | $5,645 | $5,886 |
| % Margin | 42.9% | 51.4% | 54.3% | 52.9% |
| R&D Expenses | $3,530 | $3,567 | $2,656 | $1,838 |
| G&A Expenses | $7,703 | $7,724 | $8,929 | $6,977 |
| SG&A Expenses | $12,648 | $11,680 | $12,374 | $9,400 |
| Sales & Mktg Exp. | $4,945 | $3,956 | $3,445 | $2,423 |
| Other Operating Expenses | $538 | $1,030 | $801 | $574 |
| Operating Expenses | $16,716 | $16,277 | $15,831 | $11,812 |
| Operating Income | -$12,728 | -$11,169 | -$10,186 | -$5,925 |
| % Margin | -137% | -112.5% | -97.9% | -53.2% |
| Other Income/Exp. Net | $230 | $70 | -$60 | -$3,037 |
| Pre-Tax Income | -$12,498 | -$11,099 | -$10,246 | -$8,962 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$12,498 | -$11,099 | -$10,246 | -$8,962 |
| % Margin | -134.5% | -111.8% | -98.5% | -80.5% |
| EPS | -17.58 | -1.23 | -20.47 | -24.51 |
| % Growth | -1,329.3% | 94% | 16.5% | – |
| EPS Diluted | -17.58 | -24.55 | -20.44 | -24.51 |
| Weighted Avg Shares Out | 711 | 452 | 442 | 409 |
| Weighted Avg Shares Out Dil | 711 | 452 | 442 | 409 |
| Supplemental Information | – | – | – | – |
| Interest Income | $44 | $340 | $169 | $11 |
| Interest Expense | $220 | $231 | $239 | $2,103 |
| Depreciation & Amortization | -$56 | $2,066 | $1,205 | $1,004 |
| EBITDA | -$12,728 | -$8,803 | -$8,802 | -$5,855 |
| % Margin | -137% | -88.7% | -84.6% | -52.6% |